Cheung, K.W.K.; Tang, Y.; Anders, D.; Barata, T.; Scalori, A.; Agarwal, P.; Sane, R.; Cheeti, S.
Exploring the Impact of Hepatic Impairment on Pralsetinib Pharmacokinetics. Pharmaceutics 2024, 16, 564.
https://doi.org/10.3390/pharmaceutics16040564
AMA Style
Cheung KWK, Tang Y, Anders D, Barata T, Scalori A, Agarwal P, Sane R, Cheeti S.
Exploring the Impact of Hepatic Impairment on Pralsetinib Pharmacokinetics. Pharmaceutics. 2024; 16(4):564.
https://doi.org/10.3390/pharmaceutics16040564
Chicago/Turabian Style
Cheung, Kit Wun Kathy, Yang Tang, Doreen Anders, Teresa Barata, Astrid Scalori, Priya Agarwal, Rucha Sane, and Sravanthi Cheeti.
2024. "Exploring the Impact of Hepatic Impairment on Pralsetinib Pharmacokinetics" Pharmaceutics 16, no. 4: 564.
https://doi.org/10.3390/pharmaceutics16040564
APA Style
Cheung, K. W. K., Tang, Y., Anders, D., Barata, T., Scalori, A., Agarwal, P., Sane, R., & Cheeti, S.
(2024). Exploring the Impact of Hepatic Impairment on Pralsetinib Pharmacokinetics. Pharmaceutics, 16(4), 564.
https://doi.org/10.3390/pharmaceutics16040564